NVTA

Invitae Corporation

1.20
0.00 (0.0%)
Company Name Stock Ticker Symbol Market Type
Invitae Corporation NVTA NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.20 19:19:49
Open Price Low Price High Price Close Price Prev Close
1.20 1.17 1.30 1.18 1.20
more quote information »

Recent News

Date Time Source Heading
5/31/202306:59PRNUSInvitae to Present at the William Blair 43rd Annual Growth..
5/26/202308:01PRNUSNew Research Insights to be Presented by Invitae at the 2023..
5/25/202319:00PRNUSInvitae Announces CFO Transition and Selection of Veteran..
5/24/202317:08EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
5/18/202316:28EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202316:26EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202316:07PRNUSInvitae to Appeal Trial Verdict
5/09/202316:46EDGARQuarterly Report (10-q)
5/09/202316:13EDGARCurrent Report Filing (8-k)
5/09/202316:01PRNUSInvitae Reports First Quarter 2023 Financial Results
5/01/202316:19EDGARStatement of Changes in Beneficial Ownership (4)
5/01/202316:19EDGARStatement of Changes in Beneficial Ownership (4)
5/01/202316:18EDGARStatement of Changes in Beneficial Ownership (4)
5/01/202316:17EDGARStatement of Changes in Beneficial Ownership (4)
4/26/202306:59PRNUSInvitae to Announce First Quarter 2023 Financial Results on..
4/24/202316:03EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/19/202316:28EDGARAnnual Report to Security Holders (ars)
4/19/202316:18EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/19/202316:16EDGARProxy Statement (definitive) (def 14a)
4/17/202316:30PRNUSInvitae Publishes Annual Environmental, Social and..
4/13/202308:45PRNUSNew Study Findings Published in Nature Show Circulating..
4/03/202316:32EDGARProxy Statement - Notice of Shareholders Meeting..
3/22/202307:30PRNUSInvitae and Deerfield Management Partner to Create Novel..
3/21/202307:30PRNUSInvitae Announces Partnership with Epic to Streamline..
3/16/202307:30PRNUSInvitae Appoints Dr. W. Michael Korn as Chief Medical..
3/15/202317:30PRNUSInvitae to Present Data at The American Clinical Genetics..
3/15/202316:38EDGARStatement of Changes in Beneficial Ownership (4)
3/14/202317:05EDGARCurrent Report Filing (8-k)
3/08/202307:03EDGARCurrent Report Filing (8-k)
3/06/202307:30PRNUSInvitae's PCM Assay for Minimal Residual Disease Receives..
3/01/202316:05PRNUSInvitae to Present at the TD Cowen 43rd Annual Health Care..
3/01/202307:03EDGARCurrent Report Filing (8-k)
3/01/202306:52EDGARPost-effective Amendment to Registration Statement (pos Am)
3/01/202306:28EDGARPost-effective Amendment to Registration Statement (pos Am)
2/28/202317:15EDGARAnnual Report (10-k)
2/28/202316:25EDGARCurrent Report Filing (8-k)
2/28/202316:15PRNUSInvitae Announces Convertible Notes and Share Exchange and..
2/28/202316:10PRNUSInvitae Reports Fourth Quarter and Full Year 2022 Financial..
2/14/202307:00PRNUSInvitae to Announce Fourth Quarter and Full Year 2022..
2/14/202306:22EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202313:37EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202310:30EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202311:37EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202316:38EDGARCurrent Report Filing (8-k)
2/03/202306:11EDGARAmended Statement of Ownership (sc 13g/a)
1/30/202316:26EDGARStatement of Changes in Beneficial Ownership (4)
1/30/202316:23EDGARInitial Statement of Beneficial Ownership (3)
1/30/202307:30PRNUSInvitae Appoints William H. Osborne to its Board of..
1/25/202310:38EDGARStatement of Ownership (sc 13g)
1/10/202314:19EDGARCurrent Report Filing (8-k)